{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:10:01Z","timestamp":1772107801891,"version":"3.50.1"},"reference-count":0,"publisher":"Knowledge E DMCC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJHOSCR"],"abstract":"<jats:p>Background: Cytomegalovirus (CMV) reactivation remains a critical concern following allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in CMV-seropositive patients undergoing allo-HSCT from alternative donors. This study explored whether a hybrid CMV prophylaxis regimen would be more effective than the standard preemptive regimen\u00a0in resource-limited settings where Letermovir is unavailable or cost-prohibitive.\r\nMaterials and Methods: This prospective single-center cohort study included adult patients with acute leukemia who received allo-HSCT from alternative donors between November 2018 and May 2022. The primary outcome was the evaluation of the CMV reactivation incidence in allo-HSCT patients receiving the hybrid CMV prophylaxis regimen comprising pretransplant ganciclovir followed by high-dose valacyclovir compared with the control patients who received the preemptive regimen. Secondary outcomes included overall survival (OS), disease-free survival (DFS), GVHD-free relapse-free survival (GRFS), and non-relapse mortality (NRM) between the two groups.\u00a0\u00a0 \u00a0\u00a0\r\nResults: A total of 80 patients, 34 receiving hybrid CMV prophylaxis and 46 received the preemptive protocol. The hybrid prophylaxis group exhibited a significantly lower incidence of CMV reactivation at 90 days post-transplantation (34% vs. 82%,\u00a0P\u00a0= 0.000). However,\u00a0no statistically significant differences were observed in the overall survival, disease-free survival, or non-relapse mortality.\r\nConclusion: The hybrid regimen reduced CMV reactivation in high-risk HSCT recipients but did not improve survival outcomes, offering a practical alternative in settings with limited access to Letermovir.<\/jats:p>","DOI":"10.18502\/ijhoscr.v19i4.19979","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:58:37Z","timestamp":1760954317000},"source":"Crossref","is-referenced-by-count":0,"title":["Hybrid Ganciclovir\/Valacyclovir Prophylaxis Reduces CMV Reactivation in High-Risk Allogeneic Stem Cell Transplant Recipients"],"prefix":"10.18502","author":[{"given":"Maryam","family":"Barkhordar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirabbas","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Alijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seied Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar Tavakoli","family":"Shiraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Abbaszadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosein Kamranzadeh","family":"Fumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanaz","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7770","published-online":{"date-parts":[[2025,10,20]]},"container-title":["International Journal of Hematology-Oncology and Stem Cell Research"],"original-title":[],"link":[{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/download\/19979\/18545","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/download\/19979\/18545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:26:08Z","timestamp":1772105168000},"score":1,"resource":{"primary":{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/view\/19979"},"secondary":[{"URL":"https:\/\/ijhoscr.tums.ac.ir\/index.php\/ijhoscr\/article\/view\/2465","label":"UNIVERSITY"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18502\/ijhoscr.v19i4.19979","relation":{},"ISSN":["2008-2207"],"issn-type":[{"value":"2008-2207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}